129 related articles for article (PubMed ID: 34397724)
41. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
42. Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?
Zarić B; Kuruc V; Milovančev A; Markovic M; Šarčev T; Čanak V; Pavlović S
Lung; 2008; 186(4):233-240. PubMed ID: 18357489
[TBL] [Abstract][Full Text] [Related]
43. A novel biomarker for pleural effusion diagnosis: Interleukin-36γ in pleural fluid.
Guo L; Zhang Q; Lv C; Ma X; Song X; Huang J; Chen W; Li C; Ding Q
J Clin Lab Anal; 2023 Jan; 37(1):e24799. PubMed ID: 36478612
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
Xu CH; Zhan P; Yu LK; Zhang XW
Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
[TBL] [Abstract][Full Text] [Related]
46. Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.
Chen KY; Feng PH; Chang CC; Chen TT; Chuang HC; Lee CN; Su CL; Lin LY; Lee KY
Int J Gen Med; 2016; 9():183-9. PubMed ID: 27354819
[TBL] [Abstract][Full Text] [Related]
47. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
48. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
49. Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Lee J; Park JE; Choi SH; Seo H; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2022 Jan; 37(1):137-145. PubMed ID: 33045810
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
Wu J; Lei L; Wang S; Gu D; Zhang J
J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
[TBL] [Abstract][Full Text] [Related]
52. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
53. Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study.
Perlepe G; Varsamas C; Petinaki E; Antonopoulos D; Daniil Z; Gourgoulianis KI
J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575641
[TBL] [Abstract][Full Text] [Related]
54. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
Bao Q; Xu Y; Ding M; Chen P
Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
[TBL] [Abstract][Full Text] [Related]
55. T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions.
Roofchayee ND; Adcock IM; Marjani M; Dezfuli NK; Varahram M; Garssen J; Mortaz E
Front Immunol; 2021; 12():780453. PubMed ID: 34925358
[TBL] [Abstract][Full Text] [Related]
56. High IL-35 pleural expression in patients with tuberculous pleural effusion.
Dong X; Yang J
Med Sci Monit; 2015 May; 21():1261-8. PubMed ID: 25935866
[TBL] [Abstract][Full Text] [Related]
57. Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion.
Dalil Roofchayee N; Marjani M; Dezfuli NK; Tabarsi P; Moniri A; Varahram M; Adcock IM; Mortaz E
Sci Rep; 2021 Jan; 11(1):660. PubMed ID: 33436672
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.
Sharma A; Agrawal A; Sindhwani G; Sharma A; Tomo S; Charan J; Yadav D; Sharma P
Pleura Peritoneum; 2021 Jun; 6(2):83-90. PubMed ID: 34179342
[TBL] [Abstract][Full Text] [Related]
59. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
Hamann J; Vogel B; van Schijndel GM; van Lier RA
J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
[TBL] [Abstract][Full Text] [Related]
60. Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions.
Yeo CD; Kim JW; Cho MR; Kang JY; Kim SJ; Kim YK; Lee SH; Park CK; Kim SH; Park MS; Yim HW; Park JY
Tuberc Respir Dis (Seoul); 2013 Dec; 75(6):244-9. PubMed ID: 24416055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
